Literature DB >> 30044110

Impaired post-irradiation survival of cyclooxygenase-2-deficient mice.

M Hofer1, Z Hoferová, A Gruzdev, L Dušek, M Falk.   

Abstract

We investigated and evaluated post-irradiation survival in cyclooxygenase-2-deficient (COX-2 KO) mice. Thirty-day survival following exposure of COX-2 KO mice to a lethal dose of 8.5 Gy of gamma-rays was observed to be statistically significantly lower in both males and females, as well as when the sexes were merged, in comparisons with their wild-type counterparts. These findings were related to the previous observations concerning the detrimental influence of the COX-2 genetic disruption on hematopoiesis in sublethally irradiated mice. Deteriorated post-irradiation survival of COX-2 KO mice confirmed the previously anticipated conclusion regarding negative influence of the antiinflammatory action of COX-2 deficiency under the conditions of exposure of the animals to ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30044110      PMCID: PMC7385709          DOI: 10.33549/physiolres.933890

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  10 in total

Review 1.  The coxibs, selective inhibitors of cyclooxygenase-2.

Authors:  G A FitzGerald; C Patrono
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

2.  Hematological profile of untreated or ionizing radiation-exposed cyclooxygenase-2-deficient mice.

Authors:  M Hofer; Z Hoferová; L Dušek; K Souček; A Gruzdev
Journal:  Physiol Res       Date:  2017-04-12       Impact factor: 1.881

3.  A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice.

Authors:  M Hofer; M Pospíšil; L Dušek; Z Hoferová; L Weiterová
Journal:  Radiat Res       Date:  2011-06-10       Impact factor: 2.841

Review 4.  Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.

Authors:  Paola Patrignani; Carlo Patrono
Journal:  Biochim Biophys Acta       Date:  2014-09-28

Review 5.  Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases.

Authors:  Anita-Marie Rayar; Nathalie Lagarde; Clotilde Ferroud; Jean-Francois Zagury; Matthieu Montes; Maite Sylla-Iyarreta Veitia
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

Review 6.  Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Ingvar Bjarnason; Carmelo Scarpignato; Erik Holmgren; Michael Olszewski; Kim D Rainsford; Angel Lanas
Journal:  Gastroenterology       Date:  2017-12-06       Impact factor: 22.682

Review 7.  Radiation triggering immune response and inflammation.

Authors:  Nezih Hekim; Zafer Cetin; Zacharenia Nikitaki; Aysegul Cort; Eyup Ilker Saygili
Journal:  Cancer Lett       Date:  2015-04-21       Impact factor: 8.679

8.  Inhibition of cyclooxygenase 2 in mice increases production of g-csf and induces radioprotection.

Authors:  M Hofer; M Pospísil; J Holá; A Vacek; D Streitová; V Znojil
Journal:  Radiat Res       Date:  2008-11       Impact factor: 2.841

9.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

Authors:  S G Morham; R Langenbach; C D Loftin; H F Tiano; N Vouloumanos; J C Jennette; J F Mahler; K D Kluckman; A Ledford; C A Lee; O Smithies
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

10.  Agonist of the adenosine A3 receptor, IB-MECA, and inhibitor of cyclooxygenase-2, meloxicam, given alone or in a combination early after total body irradiation enhance survival of γ-irradiated mice.

Authors:  Michal Hofer; Milan Pospíšil; Ladislav Dušek; Zuzana Hoferová; Denisa Komůrková
Journal:  Radiat Environ Biophys       Date:  2013-11-22       Impact factor: 1.925

  10 in total
  1 in total

Review 1.  Brief Story on Prostaglandins, Inhibitors of their Synthesis, Hematopoiesis, and Acute Radiation Syndrome.

Authors:  Michal Hofer; Zuzana Hoferová; Martin Falk
Journal:  Molecules       Date:  2019-11-06       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.